Ledger.Open graph →
SEC Form D · filed September 23, 2022

Arpeggio Biosciences, Inc

Offering
$20.3M
Sold
$20.2M
Exemption
Rule 506(b)
Industry
Other Technology
Location
BOULDER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Laura G. Norris · BOULDER, COExec · DirectorJoseph G. Azofeifa · BOULDER, COExec · DirectorTimothy G. Read · BOULDER, COExec · DirectorEric G. Martin · BOULDER, COExecShekhar K. Varanasi · San Jose, CAExec · DirectorDaniel K. Flynn · San Jose, CAExec · DirectorAshley J. Gautreaux · Charlotte, NCExec · DirectorAmit G. Mehta · BOULDER, CODirectorJude Panetta · Mt. Olive, NJExec · DirectorCarleton Miller · Mt. Olive, NJExec · DirectorBrian Krolicki · Mt. Olive, NJExec · DirectorAmit G. Mehta · BOULDER, CODirectorEric G. Martin · BOULDER, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗